Scoopfeeds — Intelligent news, curated.
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
business

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Yahoo Finance · May 25, 2026, 7:54 PM

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop